Cargando…

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283

Detalles Bibliográficos
Autores principales:	Demetriou, Victoria L, Kostrikis, Leondios G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316079/ http://dx.doi.org/10.1186/1742-4690-7-S1-P28

Ejemplares similares

Molecular epidemiology and genetic analysis of HCV infection in Cyprus within an intravenous drug user study cohort
por: Iacovides, Demetris C, et al.
Publicado: (2012)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Near-Full Genome Characterisation of Two Natural Intergenotypic 2k/1b Recombinant Hepatitis C Virus Isolates
por: Demetriou, Victoria L., et al.
Publicado: (2011)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts
por: Demetriou, Victoria L, et al.
Publicado: (2011)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015)

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
por: Kaushik-Basu, Neerja, et al.
Publicado: (2008)

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
por: Gao, Min, et al.
Publicado: (2010)

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
por: Bagaglio, Sabrina, et al.
Publicado: (2018)

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
por: Paolucci, Stefania, et al.
Publicado: (2013)

Influx of uncommon HIV-1 strains from Eastern Europe and identification of a new unique recombinant strain among young Cypriot MSM in Cyprus
por: Kousiappa, Ioanna, et al.
Publicado: (2012)

HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection
por: Paraskevis, Dimitrios, et al.
Publicado: (2019)

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation
por: Malheiro, Adriana, et al.
Publicado: (2010)

Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
por: Sasongko, Priyo
Publicado: (2006)

Comparative evaluation of screening and supplementary assays used in HCV diagnosis
por: Nerurkar, Vidya, et al.
Publicado: (2012)

Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
por: Olariu, Mihai, et al.
Publicado: (2013)

P292: HCV transmission in a gastroenterology endoscopy unit
por: Caballero, M Cantero, et al.
Publicado: (2013)

Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine
por: Wang, Maolin, et al.
Publicado: (2012)

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia
por: Aissa Larousse, Jameleddine, et al.
Publicado: (2015)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
por: Manfredi, Roberto, et al.
Publicado: (2010)

Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit
por: Palanisamy, Saraswathy, et al.
Publicado: (2012)

Hepatitis C diagnosics: clinical evaluation of the HCV-core antigen determination
por: van Helden, Josef
Publicado: (2014)

Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
por: Daia-Iliescu, Sînziana, et al.
Publicado: (2014)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

VAPC, an Human Endogenous Inhibitor for Hepatitis C Virus (HCV) Infection, Is Intrinsically Unstructured but Forms a “Fuzzy Complex” with HCV NS5B
por: Goyal, Shaveta, et al.
Publicado: (2012)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
por: Karpiński, Tomasz M., et al.
Publicado: (2023)

Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
por: Deloof, ACA, et al.
Publicado: (2010)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Transmission of HIV, HBV, HCV in health settings: an anthropological approach on hygiene in Cambodia
por: Hancart-Petitet, Pascale, et al.
Publicado: (2011)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
por: Costantino, Angela, et al.
Publicado: (2015)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Host genetics of HCV disease — IL28B
por: Fellay, J
Publicado: (2010)

A39 Genetic diversity of the hepatitis C virus NS5B gene during HIV/HCV co-infection
por: Blackard, Jason T
Publicado: (2018)

Molecular epidemiology and drug resistance prevalence of strains from newly diagnosed HIV-1 patients in Northern Greece during 2009-2010
por: Antoniadou, Zoe, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gh33semoj4obtqh8f72clvd6gn